Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors

GLIA

Volumn 53, Issue 6, 2006, Pages 660-668

  Hayashi, Yoshinori ^a   Ishibashi, Hitoshi ^b   Hashimoto, Kenji ^c   Nakanishi, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Glycine; Hippocampal CA1 neurons; Microglial conditioned medium; N methyl D aspatate receptor

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; GLYCINE; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL INTERACTION; CONCENTRATION (PARAMETERS); DOWN REGULATION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MICROGLIA; NERVE INJURY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR SENSITIVITY; SECRETORY CELL; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL; VOLTAGE CLAMP;

ANIMALS; ANIMALS, NEWBORN; CELL COMMUNICATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GLYCINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MICE; MICE, INBRED C57BL; MICROGLIA; N-METHYLASPARTATE; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; SYNAPTIC TRANSMISSION;

EID: 33645979933     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20322     Document Type: Article

References (40)

1. Abe K, Xie F, Watanabe Y, Saito H. 1990. Glycine facilitates induction of long-term potentiation of evoked potential in rat hippocampus. Neurosci Lett 117:87-92.
2. Akaike N, Kaneda M, Hori N, Krishtal OA. 1988. Blockade of N-methyl-D-aspartate response in enzyme-treated rat hippocampal neurons. Neurosci Lett 87:75-79.
3. Akaike N, Moorhouse A. 2002. Techniques: applications of the nerve-bouton preparation in neuropharmacology. Trends Pharmacol Sci 24:44-47.
4. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration. Causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491.
5. Flavin MP, Zhao G, Ho LT. 2000. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29:347-354.
6. Folden AM, Li S, Combs CK. 2005. β-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis α and NMDA receptors. J Neurosci 25:2566-2575.
7. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119-137.
8. Giulian D, Vaca K, Corpuz M. 1993. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13:29-37.
9. Giulian D, Vaca K, Noonan CA. 1990. Secretion of neurotoxin by mononuclear phagocytes infected with HIV-1. Science 250:1593-1596.
10. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M. 2005. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naïve schizophrenic patients. BMC Psychiatry 5:1-6.
11. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, et al. 2003. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60:572-576.
12. Hegg CC, Thayer SA. 1999. Monopcytic cells secrete factors that evoke excitatory synaptic activity in rat hippocampal culture. Eur J Pharmacol 385:231-237.
13. Jarvis CR, Xiong ZG, Plant JR, Churchill D, Lu WY, MacVicar BA, MacDonald JF. 1997. Neurotrophin modilation of NMDA receptors in cultures murine and isolated rat neurons. J Neurophysiol 78:2363-2371.
14. Johnson WJ, Ascher P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531.
15. Kinney GG, Sur C, Burno M, Mallorga PJ, Williams JB, Figuerona DJ, Wittmann M, Lemaire W, Conn PJ. 2003. The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23:7586-7591.
16. Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R. 2004. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol 557:489-500.
17. Matsui T, Sekiguchi M, Hashimoto A, Tomita U, Nishikawa T, Wada K. 1995. Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neuroche 65:454-458.
18. Mayer ML, Vyklicky JrK, Clements J. 1989. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338:425-427.
19. Miller RF. 2004. D-Serine as a glial modulator of nerve cells. Glia 47:275-283.
20. Mittmann S, Luhmann HJ, Schmidt-Kastner R, Eysel UT, Weigel H, Heinemann U. 1994. Lesion-induced transient suppression of inhibitory function in rat neocortex in vitro. Neuroscience 60:891-906.
21. Miyazaki S, Katayama Y, Furuichi M, Kano T, Yoshino T, Tsubokawa T. 1994. N-methyl-D-aspartate receptor mediated, prolonged after discharges of CA1 pyramidal cells following transient cerebral ischemia in the rat hippocampus. Brain Res 657:325-329.
22. Moriguchi S, Mizoguchi Y, Tomimatsu Y, Hayashi Y, Kadowaki T, Kagamiishi Y, Katsube N, Yamamoto K, Inoue K, Watanabe S, et al. 2003. Potentiation of NMDA receptor-mediated synaptic responses by microglia. Mol Brain Res 119:160-169.
23. Murase K, Ryu PD, Randic M. 1989. Excitatory and inhibitory amino acids - and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 103:56-63.
24. Nakanishi H. 2003a. Microglial functions and proteases. Mol Neurobiol 27:163-176.
25. Nakanishi H. 2003b. Microglial proteases: strategic targets for neuroprotective agents. Curr Neuropharmacol 1:99-108.
26. Nicoll RA, Malenka RC. 1999. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann N Y Acad Sci 868:515-525.
27. Rhee JS, Ishibashi H, Akaike N. 1999. Calcium channels in the GABAergic presynaptic nerve terminals projecting to Meynert neurons of the rat. J Neurochem 72:800-807.
28. Sastradipura DF, Nakanishi H, Tsukuba K, Nishishita K, Sakai H, Kato Y, Gotow T, Uchiyama Y, Yamamoto K. 1998. Identification of cellular compartment involved in processing of cathepsin E in primary cultures of rat microglia. J Neurochem 70:2045-2056.
29. Sugita H, Kuwabara Y, Toku K, Doi L, Yang L, Minota J, Furuya S, Hirabayashi Y, Maeda N, Sakanaka M, et al. 2001. L-Serine regulates the activities of microglial cells that express very low level of 3-phosphoglycerate dehydrogenase, an enzyme for L-serine biosynthesis. J Neurosci Res 64:392-401.
30. Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, Suzumura A. 2005. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem 280:10444-10454.
31. Thomson AM, Walker VE, Flynn DM. 1989. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature 338:422-424.
32. Tomimatsu Y, Idemoto S, Moriguchi S, Watanabe S, Nakanishi H. 2002. Proteases involved in long-term potentiation. Life Sci 72:355-361.
33. Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT. 2004. Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype. Proc Natl Acad Sci USA 101:8485-8490.
34. Tsuda M, Inoue K, Salter MW. 2005. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28:101-107.
35. Watkins LR, Maier SF. 2005. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Int Med 257:139-155.
36. Wu SZ, Bodles AM, Porter MM, Griffin WST, Basile AS, Barger SW. 2004. Induction of serine racemase expression and D-serine released from microglia by amyloid β-peptide. J Neuroinflammation 1:2-12.
37. Xiong H, McCabe L, Costello J, Anderson E, Weber G, Ikezu T. 2004. Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: implication for the pathogenesis of Alzheimer's disease. Neurobiol Ageing 25:905-911.
38. Yang S, Liu ZW, Qiao HF, Zhou WX, Zhang YX. 2005. Interleukin-1 β enhances NMDA receptor-mediated current but inhibits excitatory transmission. Brain Res 1034:172-179.
39. Yang Y, Ge W, Chen Y, Zhang Z, Shen W, Wu C, Poo M, Duan S. 2003. Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc Natl Acad Sci USA 100:15194-15199.
40. Ye JH, Tao L, Zalcman SS. 2001. Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons. Brain Res 894:241-248.